Search Results 31-40 of 17334 for Hypercalcemia

  1. Denosumab-kyqq (subcutaneous route) - Side effects & uses - Mayo Clinic

    It is also used to treat hypercalcemia (high calcium in the blood) associated with cancer that did not respond to bisphosphonate treatment. This medicine is to ...

  2. The role of focused parathyroidectomy - Mayo Clinic

    Primary hyperparathyroidism (HPT) is the most common cause of hypercalcemia, affecting as many as 1 in 750 people and 1 in 500 women over the age of 60 years.

  3. Hypoparathyroidism: Causes, presentation and advances in treatment - Mayo Clinic

    Avoidance of hypercalciuria, maintaining urinary calcium excretion within normal limits; Avoidance of hypercalcemia; Avoidance of renal and other extraskeletal ...

  4. Recurrent primary hyperparathyroidism in a patient with multiple endocrine neoplasia, type 1: A case from the endocrine teaching clinics - Mayo Clinic

    The calcium level the day after the procedure was 9.6 mg/dL, and the vascularity of the parathyroid tissue resolved. However, recurrent hypercalcemia two years ...

  5. Denosumab-bbdz (subcutaneous route) - Side effects & uses - Mayo Clinic

    It is also used to treat hypercalcemia (high calcium in the blood) associated with cancer that did not respond to bisphosphonate treatment. This medicine is to ...

  6. Denosumab-mobz (subcutaneous route) - Side effects & uses - Mayo Clinic

    Hypercalcemia may occur after stopping treatment in patients with growing bones. Tell your doctor right away if you have confusion, constipation, depression ...

  7. Parathyroid hormone (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Severe hypercalcemia (high calcium in the blood) may occur while using this medicine. This is more likely to occur when you start treatment or increase your ...

  8. Denosumab-bmwo (subcutaneous route) - Side effects & uses - Mayo Clinic

    Hypercalcemia may occur after stopping treatment in patients with growing bones. Tell your doctor right away if you have confusion, constipation, depression ...

  9. Denosumab-qbde (subcutaneous route) - Side effects & uses - Mayo Clinic

    Hypercalcemia may occur after stopping treatment in patients with growing bones. Tell your doctor right away if you have confusion, constipation, depression ...

  10. Etidronate (oral route) - Side effects & dosage - Mayo Clinic

    For treating hypercalcemia (too much calcium in the blood):. Adults—Dose is based on body weight and must be determined by your doctor. The dose is usually ...